Clinical Library
Protocol Guides
Deep-dive clinical protocols for every compound we offer — and a few we don't. Dosing, timing, lab markers, and the honest caveats your provider should mention.
CJC-1295 / Ipamorelin
The gold-standard GH secretagogue stack — titration protocols, timing windows, and what to expect month by month.
Read Guide Growth HormoneTesamorelin
FDA-approved GHRH analog for visceral fat reduction — clinical dosing, lipodystrophy data, and metabolic markers.
Read Guide Growth HormoneSermorelin
The original GH secretagogue — reconstitution steps, subcutaneous injection guide, and IGF-1 monitoring.
Read Guide RecoveryBPC-157
Gastric pentadecapeptide for tissue repair — oral vs injectable routes, gastric vs systemic protocols.
Read Guide Sexual HealthPT-141 (Bremelanotide)
Melanocortin-4 receptor agonist for hypoactive sexual desire — syringe math, nausea management, and timing.
Read Guide NeuropeptideOxytocin
Intranasal oxytocin protocols — sex-differentiated dose responses, bonding effects, and clinical limitations.
Read Guide MitochondrialMethylene Blue
Electron carrier and mitochondrial enhancer — SSRI contraindication risks, hormetic dosing, and cognitive effects.
Read Guide ImmuneThymosin Alpha-1
Thymic peptide for immune modulation — clinical trial evidence, hepatitis data, and autoimmune considerations.
Read Guide Skin & TissueGHK-Cu
Copper tripeptide for collagen remodeling — the 'Copper Uglies' titration phase and topical vs injectable routes.
Read Guide MetabolicMOTS-c
Mitochondrial-derived peptide for metabolic regulation — WADA prohibition status and exercise-mimetic effects.
Read Guide MitochondrialNAD+
Nicotinamide adenine dinucleotide therapy — IV vs oral bioavailability critique and longevity pathway evidence.
Read Guide SleepDSIP
Delta sleep-inducing peptide — the 15-minute half-life problem, circadian timing, and realistic expectations.
Read Guide Research ChemicalIbutamoren (MK-677)
Oral ghrelin mimetic for GH secretion — why VitalRx doesn't offer it, blood glucose risks, and WADA status.
Read Guide MitochondrialElamipretide
Cardiolipin stabilizer for mitochondrial dysfunction — FDA approval impact on compounding and the MOTS-c bridge.
Read Guide Weight ManagementTesofensine (NS-2330)
Triple monoamine reuptake inhibitor with Phase IIb data — cardiovascular signal, cycling myths, and the gray market quality problem.
Read Guide NeuropeptideSelank (TP-7)
Tuftsin analog anxiolytic with Russian RCT data — the spray bottle problem, GABA gene-expression mechanism, and 14-day course protocol.
Read Guide